Product Information
SODIUM BICARB 325 MG TABLET is a generic product labeled by Rugby Laboratories, priced at $0.0147 per EA under NDC 00536104610. Its NADAC has been published 495 times since May 13, 2015.
Strength
325 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536104610
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SODIUM BICARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M001On Market Since
3/25/2015
Pharmacological Classes
Price Statistics
The NADAC for SODIUM BICARB 325 MG TABLET has been published 495 times since May 13, 2015, and over the history we have for it it has declined 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0147 per EA |
|---|---|
| All-time high | $0.0212 (Dec 11, 2019) |
| All-time low | $0.0132 (Jun 19, 2024) |
| 52-week high | $0.0151 |
| 52-week low | $0.0140 |
| Median price | $0.0157 |
| Average price | $0.0159 |
| Largest weekly change | +36.0% (May 17, 2017) |
| Weeks tracked | 495 |
| Tracking since | May 13, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sodium Bicarbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Bicarbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SODIUM BICARB 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM BICARB 325 MG TABLET, manufactured by Rugby Laboratories, is $0.0147 per EA (NDC 00536104610), effective Sep 30, 2026.
How has the price of SODIUM BICARB 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for SODIUM BICARB 325 MG TABLET has declined 7.4%. It has been tracked across 495 weekly CMS publications since May 13, 2015.
What are the highest and lowest recorded NADAC prices for SODIUM BICARB 325 MG TABLET?
Since May 13, 2015, the NADAC for SODIUM BICARB 325 MG TABLET has ranged from a low of $0.0132 (Jun 19, 2024) to a high of $0.0212 (Dec 11, 2019), with a median of $0.0157 per EA.
Are there cheaper alternatives to SODIUM BICARB 325 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SODIUM BICARB 325 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SODIUM BICARB 325 MG TABLET?
SODIUM BICARB 325 MG TABLET (NDC 00536104610) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.